Perspective Therapeutics Profit Margin

The latest profit margin for CATX is -31812.57% as of June 2026. That compares with -19728.65% in the prior-year period — down 61.3% year over year. That is below the Industrials sector average of 4.71%. Investors often review this figure alongside Perspective Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, CATX's profit margin moved from -19728.65% to -31812.57% — a 61.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Perspective Therapeutics's valuation or profitability profile.

Against Industrials companies, CATX currently prints -31812.57% for profit margin, while the sector average sits near 4.71%. That is roughly 676234.8% below the sector mean. Large gaps often invite a closer look at Perspective Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively Perspective Therapeutics converts resources into returns. At -31812.57%, CATX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -19728.65% in the prior-year period — down 61.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CATX's profit margin (-31812.57%), review year-over-year change from -19728.65%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.